Symposium

Immune Checkpoint Blockade and the Transformation of Cancer Therapy

In honor of James Allison, Lieping Chen, Gordon Freeman, Tasuku Honjo and Arlene Sharpe for contributions to the pre-clinical foundation and development of immune checkpoint blockade, a novel form of cancer therapy that has transformed the landscape of cancer treatment.

Featured Speakers Include:

Jim Allison, Ph.D.
Professor of immunology and chair of the Department of Immunology, The University of Texas MD Anderson Cancer Center

Lieping Chen, M.D., Ph.D.
United Technologies Corporation professor in Cancer Research and professor of immunobiology, of dermatology and of medicine, Yale University

Gordon Freeman, Ph.D.
Professor of medicine, Dana-Farber Cancer Institute, Harvard Medical School

Tasuku Honjo, M.D., Ph.D.
Professor of immunology and genomic medicine, Kyoto University

Arlene Sharpe, M.D., Ph.D.
George Fabyan Professor of Comparative Pathology, Harvard Medical School

Michael Atkins, M.D.
Deputy Director, Georgetown Lombardi Comprehensive Cancer Center

Location:

Harvard Medical School
The Joseph B.Martin Conference Center
77 Avenue Louis Pasteur
Boston, MA 02115

Open to the Public

To RSVP: HMS_Events@hms.harvard.edu

Seating available on a first come first served basis